EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1/PI3K signaling pathway

Yonghong Zheng, Guojian Xiang, Linwen Zeng, Chao Yang, Jun Ke, Huizhen Yu, Jiancheng Zhang

Cellular Signalling · 2024

DOI: 10.1016/j.cellsig.2024.111407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Yonghong Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, Fujian, China; Fuzhou University Affiliated Provincial Hospital, Fuz…. Hauptthemen laut MEDLINE: Doxorubicin, MicroRNAs, Heart Failure, Sp1 Transcription Factor. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Provincial Health Technology Project, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The goal of this research was to explore the role of miR-24-3p in heart failure (HF), with a focus on its impact on the specificity protein 1 (Sp1)/phosphoinositide 3-kinase (PI3K) pathway. METHODS: HF rat and HF cell models were established using doxorubicin(Dox). Cardiac function was assessed through echocardiography, while histological changes were observed via hematoxylin-eosin (HE) staining. To further investigate the underlying mechanisms, HF cell models were treated with either an Sp1 inhibitor or a PI3K inhibitor. Additionally, models with miR-24-3p overexpression or silencing were constructed. N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were determined by ELISA. Cell apoptosis was evaluated using TUNEL staining, and lactate dehydrogenase (LDH) levels were measured by colorimetry. Reactive oxygen species (ROS) production was analyzed using flow cytometry. Related gene and protein expressions were assessed via qRT-PCR and Western blotting. Finally, the relationship between miR-24-3p and Sp1 was confirmed through dual-luciferase assays. RESULTS: Dox treatment increased the left ventricular internal diameter (LVIDd) while decreasing ejection fraction (EF) and fractional shortening (FS), leading to disorganized cardiomyocyte arrangement, cellular edema, and necrosis in rats. In HF rats, NT-proBNP, Caspase-3, and miR-24-3p expression levels were elevated, whereas Sp1 and PI3K mRNA and protein expression levels were decreased. Similarly, Dox-induced damage in H9c2 cardiomyocytes resulted in increased NT-proBNP, apoptosis, Caspase-3, LDH, ROS, and miR-24-3p expression, along with decreased Sp1 and PI3K expression. Treatment with either Sp1 or PI3K inhibitors exacerbated the Dox-induced cardiomyocyte damage, further elevating NT-proBNP, apoptosis, Caspase-3, LDH, ROS, and miR-24-3p expression levels. Notably, Sp1 inhibition reduced PI3K expression, and PI3K inhibition, in turn, suppressed Sp1 expression. Overexpression of miR-24-3p worsened Dox-induced cardiomyocyte damage, characterized by increased NT-proBNP, apoptosis, Caspase-3, LDH, and ROS expression, alongside reduced Sp1 and PI3K expression. In contrast, silencing miR-24-3p mitigated these detrimental effects and increased Sp1 and PI3K expression. Dual-luciferase assays confirmed that miR-24-3p directly targets Sp1. CONCLUSION: Dox induces cardiomyocyte damage, impairs cardiac function, and promotes cardiomyocyte apoptosis and oxidative stress. Silencing miR-24-3p offers a protective effect by activating the Sp1/PI3K signaling pathway in heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinMicroRNAsHeart FailureSp1 Transcription FactorSignal TransductionPhosphatidylinositol 3-KinasesApoptosisRats, Sprague-DawleyMyocytes, CardiacAnimalsRatsMaleReactive Oxygen SpeciesNatriuretic Peptide, BrainHumans

Stichwörter der Autor:innen

DoxorubicinHeart failureMiR-24-3pMyocardial injurySp1/PI3K signaling pathway

Substanzen

DoxorubicinMicroRNAsSp1 Transcription FactorPhosphatidylinositol 3-KinasesMIRN24 microRNA, ratReactive Oxygen SpeciesNatriuretic Peptide, Brain

Autor:innen und Institutionen

  • Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, Fujian, China; Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, Fujian, China; Department of Cardiology, Fujian Provincial…
  • Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, Fujian, China.
  • Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, Fujian, China; Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, Fujian, China; Department of Intensive Care Medicine, Fuji…
  • Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, Fujian, China; Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, Fujian, China.
  • Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, Fujian, China; Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, Fujian, China; Department of Cardiology in South Branch, F…

Förderung

  • National Natural Science Foundation of China
  • Fujian Provincial Health Technology Project
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Zheng, Y., Xiang, G., Zeng, L., Yang, C., Ke, J., Yu, H., & Zhang, J. (2024). MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1/PI3K signaling pathway. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111407

Vancouver

Zheng Y, Xiang G, Zeng L, Yang C, Ke J, Yu H, et al. MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1/PI3K signaling pathway. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111407

BibTeX
@article{Zheng2024,
  author = {Zheng, Yonghong and Xiang, Guojian and Zeng, Linwen and Yang, Chao and Ke, Jun and Yu, Huizhen and Zhang, Jiancheng},
  title = {MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1/PI3K signaling pathway},
  journal = {Cellular Signalling},
  year = {2024},
  doi = {10.1016/j.cellsig.2024.111407}
}
Kostenlos starten →